Search Phillips' capabilities by:


Systems Engineering for Complex Portable Drug Delivery Device Development

A systems engineering approach can provide reduced risk and increased efficiency for the ever-growing requirements of smaller, smarter and more complex inhaler devices. Taking a systems engineering approach to development, provices a holistic, organized and deliverate method for identifying, as well as reducing both patient and business risks early in the process

View Article (PDF)
The Power of Drug Device Company Collaboration

When drug and device companies join forces, it can free pharmaceutical and
biotech companies to focus on their core competencies, while leveraging their
suppliers' existing, proven, regulatory-compliant design ability and
manufacturing processes and infrastructure. Bill Welch, shares a preview of his
forthcoming Pharmapack talk.

View Article (PDF)
Smoke Signals

Phillips-Medisize has used its expertise for a nicotine therapy spray device. From project to production the company was involved in the project which used automatic assembly through indexing machines.

View Article (PDF)
Human-centered Design and Inhalation Device Development

Phillips-Medisize puts human-centered design at the core of our efforts – driving more usable, intuitive, desirable devices for inhalation device patients – and is positioned to help you with the next generation of smaller, smarter inhalers.

View Article (PDF)
Smaller, Smarter, Electronic, Connected: The Next Generation of Drug Delivery Devices

Adding electronics and connectivity to drug-delivery devices is a trend
gaining momentum, particularly for drugs self-administered by patients
outside the clinical setting. The technological advancements that have been driving the consumer electronics market are now influencing new methods for drug delivery.

View Article (PDF)
Full Scale

Scalability for drug delivery begins with concurrent engineering of DFM/DFA and development of a device manufacturing concept. The manufacturing unit or CMO must be able to effectively provide these capabilities, as well as the capabilities for project management and technical execution of the plan.

View Article (PDF)
The Human Touch

During the development phases, pharma or medical device companies can encounter obstacles complying with regulations. There is also the need to manage complicated supply chain logistics. A minor detail can derail the development of a successful product, resulting in lost time and resources and deadlines missed. Tapping into the expertise of device companies also helps pharma/biotech or medical companies pitch their product project for success.

View Article (PDF)
Scalable Automation for Drug Delivery Devices

Today’s medical device and pharma industry assembly concepts can be complex. Here, Bill Welch, Chief Technology Officer, Phillips-Medisize, outlines why, therefore, the company provides a comprehensive assembly concept, tailored to customers’ needs. Scalability begins with early DFM/DFA philosophy integrated into the product development process.

View Article (PDF)
Human-centred Design At the Heart of a Successful Product Development Process

Bill Welch, Chief Technology Officer, and Jeremy Odegard, Design & Development Center, both of Phillips-Medisize, provide an insight into how the company’s human centred design approach fits into its integrated product development process.

View Article (PDF)
Extrusion and Injection Blow Moulding: Techniques for Medical Plastic Packaging

Phillips-Medisize has provided the following discussion of blow moulding. The company has a dedicated plant to injection blow moulding in Switzerland. A distinction is made between two kinds of blow moulding— extrusion and injection blow moulding. These techniques differ in terms of the manufacturing process, quality and design opportunities. We will look at these differences in more detail and compare the techniques.

View Article (PDF)


Capabilities by Market
Capabilities by Process
Capabilities by Material